MENU
BRVE Braveheart Bio Inc. Forecast, Technical & Fundamental Analysis
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases... Show more
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published Earnings
BRVE is expected to report earnings to fall 63.75% to -91 cents per share on December 08
Q3'26
Est.
$-0.91
Q2'26
Missed
by $2.26
The last earnings report on September 08 showed earnings per share of -250 cents, missing the estimate of -25 cents. With 225.50K shares outstanding, the current market capitalization sits at 1.67B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PFRL | 49.35 | 0.02 | +0.05% |
| PGIM Floating Rate Income ETF (PFRL) | |||
| PBOG | 34.85 | 0.01 | +0.02% |
| Portfolio Building Block Integrated Oil and Gas and Exploration and Production Index ETF (PBOG) | |||
| FLRN | 30.74 | N/A | N/A |
| State Street SPDR Bloomberg Investment Grade Floating Rate ETF (FLRN) | |||
| KBUF | 25.28 | N/A | N/A |
| KraneShares 90% KWEB Defined Outcome January 2027 ETF (KBUF) | |||
| MAYM | 33.28 | -0.04 | -0.11% |
| FT Vest U.S. Equity Max Buffer ETF - May (MAYM) | |||
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
One Letterman Drive
Phone
+1 415 707-6312
Employees
30
Web
https://www.braveheart.bio